Hong Nam Kim

InstitutionKorea Institute of Science and Technology (KIST)
AddressSouth Korea
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in July 2020 and November 2020 and April 2021
    All Publications
    Bar chart showing 31 publications over 12 distinct years, with a maximum of 5 publications in 2013 and 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Park HH, Kim H, Lee HS, Seo EU, Kim JE, Lee JH, Mun YH, Yoo SY, An J, Yun MY, Kang NW, Kim DD, Na DH, Hong KS, Jang JG, Ahn JH, Bae JS, Song GY, Lee JY, Kim HN, Lee W. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials. 2021 06; 273:120827. PMID: 33910079.
      Citations: 1     Fields:    Translation:HumansAnimals
    2. Kim H, Lee HS, Ahn JH, Hong KS, Jang JG, An J, Mun YH, Yoo SY, Choi YJ, Yun MY, Song GY, Joo J, Na DH, Kim HN, Park HH, Lee JY, Lee W. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm. Nano Today. 2021 Jun; 38:101149. PMID: 33846686.
      Citations: 2     
    3. Choi EY, Park HH, Kim H, Kim HN, Kim I, Jeon S, Kim W, Bae JS, Lee W. Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients. Eur Respir J. 2020 11; 56(5). PMID: 32859680.
      Citations: 8     Fields:    Translation:Humans
    4. Hong KS, Ahn JH, Jang JG, Lee JH, Kim HN, Kim D, Lee W. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 11 17; 5(1):267. PMID: 33203839.
      Citations: 2     Translation:HumansPHPublic Health
    5. Lee W, Ahn JH, Park HH, Kim HN, Kim H, Yoo Y, Shin H, Hong KS, Jang JG, Park CG, Choi EY, Bae JS, Seo YK. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020 09 03; 5(1):186. PMID: 32883951.
      Citations: 20     Translation:HumansCellsPHPublic Health
    6. Park HH, Kim HN, Kim H, Yoo Y, Shin H, Choi EY, Bae JS, Lee W. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia. Sci Adv. 2020 07; 6(31). PMID: 32937590.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    7. Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee W, Ahn JH. Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication. Infect Chemother. 2020 Sep; 52(3):396-402. PMID: 32757497.
      Citations: 6